These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25967123)

  • 41. FGF23 beyond Phosphotropic Hormone.
    Takashi Y; Fukumoto S
    Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New Developments in CKD-MBD. Development and progression of CKD-MBD in predialysis period -when and how?].
    Komaba H
    Clin Calcium; 2014 Dec; 24(12):1771-8. PubMed ID: 25423921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Cai X; Lee J; Scialla JJ; Bansal N; Sondheimer JH; Chen J; Hamm LL; Ricardo AC; Navaneethan SD; Deo R; Rahman M; Feldman HI; Go AS; Isakova T; Wolf M;
    JAMA Cardiol; 2016 Aug; 1(5):548-56. PubMed ID: 27434583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast growth factor 23 and the heart.
    Faul C
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):369-75. PubMed ID: 22531163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [FGF23 and osteonetwork].
    Fukumoto S
    Clin Calcium; 2016 Aug; 26(8):1143-7. PubMed ID: 27461497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
    Singh S; Grabner A; Yanucil C; Schramm K; Czaya B; Krick S; Czaja MJ; Bartz R; Abraham R; Di Marco GS; Brand M; Wolf M; Faul C
    Kidney Int; 2016 Nov; 90(5):985-996. PubMed ID: 27457912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
    Houston J; Smith K; Isakova T; Sowden N; Wolf M; Gutiérrez OM
    J Ren Nutr; 2013 Jan; 23(1):12-20. PubMed ID: 22406119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Correlation of fibroblast growth factor 23 with 
adverse prognosis of chronic kidney disease and
therapy strategy].
    Liu H; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):560-565. PubMed ID: 29886473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice.
    Sun N; Guo Y; Liu W; Densmore M; Shalhoub V; Erben RG; Ye L; Lanske B; Yuan Q
    Sci Rep; 2015 Feb; 5():8304. PubMed ID: 25665715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammation: a putative link between phosphate metabolism and cardiovascular disease.
    Voelkl J; Egli-Spichtig D; Alesutan I; Wagner CA
    Clin Sci (Lond); 2021 Jan; 135(1):201-227. PubMed ID: 33416083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extrarenal effects of FGF23.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2017 May; 32(5):753-765. PubMed ID: 27704252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-renal-Related Mechanisms of FGF23 Pathophysiology.
    Hanudel MR; Laster M; Salusky IB
    Curr Osteoporos Rep; 2018 Dec; 16(6):724-729. PubMed ID: 30353318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic background influences cardiac phenotype in murine chronic kidney disease.
    Neuburg S; Dussold C; Gerber C; Wang X; Francis C; Qi L; David V; Wolf M; Martin A
    Nephrol Dial Transplant; 2018 Jul; 33(7):1129-1137. PubMed ID: 29309658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What would we like to know, and what do we not know about fibroblast growth factor 23?
    Cozzolino M; Galassi A; Apetrii M; Covic A
    J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.